A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Recruiting

Phase 2

LY3938577 vs. DegludecA Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Sponsor:

Eli Lilly and Company

Code:

NCT07215312

Conditions

Diabetes Mellitus, Type 2

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

LY3938577

Degludec

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-23. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2025-12-18.